Canadian Oxygen Trial (COT)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,201

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2012

Study Completion Date

December 31, 2012

Conditions
Respiratory Insufficiency of Prematurity
Interventions
OTHER

Titration of oxygen therapy

Supplemental oxygen to maintain functional arterial oxygen saturations in one of two saturation target ranges.

Trial Locations (23)

19035

Pennsylvania Hospital, Philadelphia

19104

Hospital of the University of Pennsylvania (HUP), Philadelphia

31048

Bnai-Zion Medical Center, Haifa

44281

Meir Medical Center, Kfar Saba

84101

Soroka University Medical Center, Beersheba

11794-8111

Stony Brook University Medical Center, Stony Brook

Unknown

Hospital Sanatorio de la Trinidad & Buenos Aires NICU Network, Buenos Aires

Oulu University Central Hospital, Oulu

University Children's Hospital, Tübingen

T2N 2T9

Foothills Hospital, Calgary

T5H 3V9

Royal Alexandra Hospital, Edmonton

V6H 3V4

B.C. Children's Hospital, Vancouver

R3E 0L8

St. Boniface General Hospital, Winnipeg

R3L 0L8

Winnipeg Health Sciences Centre, Winnipeg

B3P 1R8

IWK Health Centre, Halifax

L8N 3Z5

McMaster University Medical Centre, Hamilton

K1H 8L1

Children's Hospital of Eastern Ontario and Ottawa General Hospital, Ottawa

M5G 1X5

Mount Sinai Hospital, Toronto

M5S 1B2

Sunnybrook Health Sciences Centre, Toronto

H3A 1A1

Royal Victoria Hospital, Montreal

H3T 1C5

CHU Ste. Justine, Montreal

G1L 3L5

Centre Hospitalier Universitaire de Quebec, Québec

S7N 0W8

Royal University Hospital, Saskatoon

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

McMaster University

OTHER

NCT00637169 - Canadian Oxygen Trial (COT) | Biotech Hunter | Biotech Hunter